loading

Astria Therapeutics Inc Stock (ATXS) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
29.38%
24.15
34.20 20.24 15.10 13.49
Operating Income/Loss
29.38%
-24.15
-34.20 -20.24 -15.10 -13.49
Nonoperating Income/Loss
51.38%
4.222
2.789 2.509 2.536 2.305
Income/Loss From Continuing Operations Before Tax
36.56%
-19.93
-31.41 -17.73 -12.57 -11.19
Income/Loss From Continuing Operations After Tax
36.56%
-19.93
-31.41 -17.73 -12.57 -11.19
Net Income/Loss
36.56%
-19.93
-31.41 -17.73 -12.57 -11.19
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2,366%
52.29
2.1207 28.04 28.02 27.94
Diluted Average Shares
2,366%
52.29
2.1207 28.04 28.02 27.94
Basic Earnings Per Share
59.57%
-0.38
-0.94 -0.63 -0.45 -0.40
Diluted Earnings Per Share
59.57%
-0.38
-0.94 -0.63 -0.45 -0.40
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):